telitacicept
telitacicept: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Vor Biopharma Inc. (VOR) | Phase 3 |
Clinical Trials (1)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study With an Open-label Extension Period to Evaluate the Efficacy and Safety of Telitacicept in Patients With Generalized Myasthenia Gravis
Frequently asked questions
Who is developing telitacicept?
telitacicept is being developed by Vor Biopharma Inc..
How many clinical trials involve telitacicept?
BioSniper tracks 1 clinical trial involving telitacicept.
Get deeper analysis on telitacicept
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis